LSV Asset Management »

Eagle Pharmaceuticals shares owned by LSV Asset Management

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by LSV Asset Management from 13F filings

Historical chart of LSV Asset Management investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by LSV Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by LSV Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.7M 295k 5.60
2024-03-31 $1.8M 334k 5.24
2023-12-31 $2.0M 392k 5.23
2023-09-30 $6.4M 409k 15.77
2023-06-30 $7.9M 409k 19.44
2023-03-31 $6.9M 244k 28.37
2022-12-31 $4.4M 151k 29.23
2020-12-31 $153k 3.3k 46.52
2020-09-30 $586k 14k 42.46
2020-06-30 $8.1M 169k 47.98
2020-03-31 $15M 320k 46.00
2019-12-31 $22M 369k 60.08
2019-09-30 $26M 462k 56.57
2019-06-30 $13M 250k 50.49
2019-03-31 $13M 250k 50.49
2018-12-31 $3.4M 83k 40.28
2018-09-30 $6.2M 89k 69.33
2018-06-30 $45M 593k 75.66
2018-03-31 $45M 859k 52.69
2017-12-31 $39M 734k 53.42
2017-09-30 $14M 228k 59.64